Sample Preparation Products for Next Generation Sequencing Market Report 2026

The sample preparation products for next generation sequencing market size has grown rapidly in recent years. It will grow from $42.52 billion in 2025 to $49.01 billion in 2026 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to expansion of genomics research activities, increased use of NGS in clinical research, availability of advanced extraction and library preparation kits, growth in oncology research applications, rising adoption of sequencing technologies.

The sample preparation products for next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $85.54 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing demand for precision medicine applications, expansion of clinical NGS diagnostics, rising investments in genomics research infrastructure, growing adoption of automation in laboratories, ongoing innovation in sequencing sample preparation technologies. Major trends in the forecast period include increasing adoption of automated sample preparation workflows, growing demand for high-throughput ngs sample processing, expansion of targeted sequencing panels, rising focus on workflow standardization, enhanced integration with ngs platforms.

The growing demand for precision medicine is expected to drive the expansion of sample preparation products for the next-generation sequencing market in the coming years. Personalized medicine, also referred to as precision medicine, is a medical approach that customizes treatment and healthcare strategies for individual patients based on their distinct genetic, environmental, and lifestyle factors. The rising demand for precision medicine is attributed to the increasing prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases. Sample preparation products for NGS play a crucial role in advancing precision medicine. They facilitate the accurate and efficient analysis of genetic information, which is vital for the development of targeted therapies and the enhancement of patient outcomes in personalized healthcare. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Thus, the increasing demand for precision medicine is propelling the growth of sample preparation products for the next-generation sequencing market.

Major companies operating in the sample preparation products for the next-generation sequencing market are focusing on innovations such as next-generation sequencing to strengthen their market position. Next-generation sequencing (NGS) is a transformative technology used to identify the sequence of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), allowing the examination of genetic variations and the investigation of biological processes. For example, in July 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched QIAseq Normalizer Kits. These kits provide researchers with a rapid, convenient, and cost-efficient method to pool DNA libraries, ensuring high-quality outcomes in NGS experiments. The kits are compatible with QIAGEN's QIAseq library prep solutions as well as other DNA/RNA preparation workflows for Illumina platforms.

In December 2023, PerkinElmer, a US-based technology company, acquired Covaris for an undisclosed amount. This acquisition will enable PerkinElmer to enhance its genomics solutions portfolio, offering more comprehensive tools for researchers in molecular biology and drug discovery, while improving efficiency and precision in sample preparation for NGS and other applications. Covaris is a US-based company that manufactures sample preparation products for next-generation sequencing (NGS), proteomics, and drug discovery applications.

Major companies operating in the sample preparation products for next generation sequencing market are Merck & Co. Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Promega Corporation, Oxford Nanopore Technologies Ltd, Takara Bio Inc, New England Biolabs, Fluidigm Corporation, Pacific Biosciences of California Inc., Analytik Jena AG, SeraCare Life Sciences, Diagenode Inc., Zymo Research Corporation, Nugen Technologies Inc., Swift Biosciences Inc., Tecan Group Ltd.

North America was the largest region in the sample preparation products for next generation sequencing (NGS) market in 2025. The regions covered in the sample preparation products for next generation sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sample preparation products for next generation sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the sample preparation products for next generation sequencing market by increasing costs of imported reagents, enzymes, consumables, automation instruments, and laboratory equipment used in NGS workflows. Biotechnology and pharmaceutical laboratories in North America and Europe are most affected due to reliance on imported specialized products, while Asia-Pacific faces cost pressure on research expansion. These tariffs are increasing per-sample processing costs and affecting research timelines. However, they are also encouraging domestic reagent production, localized manufacturing, and regional supply chain diversification.

The sample preparation products for next generation sequencing market research report is one of a series of new reports that provides sample preparation products for next generation sequencing market statistics, including sample preparation products for next generation sequencing industry global market size, regional shares, competitors with a sample preparation products for next generation sequencing market share, detailed sample preparation products for next generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the sample preparation products for next generation sequencing industry. This sample preparation products for next generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sample preparation products for next-generation sequencing (NGS) are specialized tools and reagents used to process biological samples, including deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), prior to sequencing. These products ensure that the genetic material is efficiently extracted, purified, and fragmented to meet the specifications of NGS platforms.

The main types of sample preparation products for next-generation sequencing include deoxyribonucleic acid (DNA) extraction, purification, and isolation products, ribonucleic acid (RNA) extraction, purification, and isolation products, panels, exome kits, and other target enrichment products, deoxyribonucleic acid (DNA) library construction or preparation products, ribonucleic acid (RNA) sequencing (SEQ), transcriptome and gene expression products, and small ribonucleic acid (RNA) next-generation sequencing sample preparation products. DNA extraction, purification, and isolation products are designed to extract DNA from biological samples such as blood, tissues, and cells. The therapeutic areas include oncology, infectious diseases, and human genetics or population genetics, and these products are applied across various fields such as biotechnology, medical research, pharmaceuticals, and others.

The sample preparation products for next generation sequencing market consists of sales of instruments, kits, reagents, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.